Email Updates

Search form

You are here

AIDS Vaccines

There is momentum and promise in the search for an AIDS vaccine.

An effective preventive AIDS vaccine would teach the body how to prevent HIV infection. Vaccines are the most powerful public health tools available—and an AIDS vaccine would play a powerful role in ensuring the end to the AIDS epidemic.

While effective vaccines remain years away, there are more reasons for hope than ever before. Researchers are expanding on the result of a 2009 trial that showed, for the first time, that a vaccine can reduce the risk of HIV infection. They’re also pursuing groundbreaking research with other novel vaccine strategies, including broadly neutralizing antibodies that target a wide range of HIV strains. At the same time, there is also exciting work in efforts to understand if and how to cure HIV in people who are already infected. The timeline for this work is long and uncertain. Here, too, advocacy is needed to sustain momentum.

Today’s momentum depends on sustained funding. Policy makers and funders around the world must have the courage to sustain vital AIDS vaccine research for years to come, and advocates must keep the pressure on them to maintain their commitments.

Key Update

New AIDS vaccine advocacy materials and tools now available for HIV Vaccine Awareness Day in 2015.

May 13, 2015
AVAC
What We're Reading

Recent discoveries are spurring a renaissance in HIV vaccine research and development.

May 1, 2015
The Scientist

In this webinar, Dr. Sarah Schlesinger of Rockefeller University provided an overview of "passive immunization"—a scientific term for an expanding area of research highly relevant to treatment, prevention and cure work. She also spoke of her research into broadly neutralizing antibodies, describing the work she and her colleagues have recently published. This webinar was just one in our year-long series, HIV Prevention on the Line.

April 21, 2015
AVAC

Bill Gates expressed that an HIV vaccine (and cure) will become a reality within 15 years. Although there are signs of progress on both fronts, the Treatment Action Group believes that existing challenges—such as funding and regulatory pathways—cannot be underestimated.

April 14, 2015
The Body

Richard Jefferys summarizes and explains new research appearing in Nature on infusing human subjects with broadly neutralizing antibodies for therapeutic and preventive use.

April 10, 2015
Subscribe to RSS - AIDS Vaccines